Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03554772 · ClinicalTrials.gov registry record · Phase 2
Efficacy, Tolerability, Safety, and Pharmacokinetic Study of DFN-15
A Phase 2 study, sponsored by Dr. Reddy's Laboratories Limited.
- Completed
- Registry status
- Phase 2
- Development phase
- 120
- Enrollment target
NCT03554772 is a Phase 2 study that has completed, run by Dr. Reddy's Laboratories Limited. The registered enrollment target is 120 participants.
The verdict
NCT03554772, a Phase 2 study, has completed, sponsored by Dr. Reddy's Laboratories Limited.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 120 participants
- Enrollment target
Study Summary
Efficacy, Tolerability, Safety and Pharmacokinetic Study of DFN-15 in Post-Surgical Dental Pain.
Interventions
- DRUG Placebo
- DRUG DFN-15 (Celecoxib Oral Solution) 62.5 mg
- DRUG DFN-15 (Celecoxib Oral Solution) 125 mg
- DRUG DFN-15 (Celecoxib Oral Solution) 250 mg
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 120 participants |
| Start Date | 2018-06-19 |
| Est. Completion | 2018-08-20 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03554772
The ClinicalTrials.gov registry entry for NCT03554772 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 120 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Dr. Reddy's Laboratories Limited, which has 52 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Placebo is the first listed.
NCT03554772 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03554772 about?
NCT03554772 is a clinical study titled "Efficacy, Tolerability, Safety, and Pharmacokinetic Study of DFN-15". Efficacy, Tolerability, Safety and Pharmacokinetic Study of DFN-15 in Post-Surgical Dental Pain.
What is the current status of trial NCT03554772?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 120 participants. The study started on 2018-06-19. Estimated completion is 2018-08-20.
What interventions are being tested in trial NCT03554772?
The interventions under investigation include: Placebo (DRUG), DFN-15 (Celecoxib Oral Solution) 62.5 mg (DRUG), DFN-15 (Celecoxib Oral Solution) 125 mg (DRUG), DFN-15 (Celecoxib Oral Solution) 250 mg (DRUG).
Who is sponsoring clinical trial NCT03554772?
This trial is sponsored by Dr. Reddy's Laboratories Limited, which has 52 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.